Skip to main content
menu

widget-a17f4254-978

  • Lueck Lab
  • Lueck Lab
  • Lueck Lab

Lueck Lab

Welcome to the Lueck Lab

The Lueck lab focuses on the molecular genetics and experimental treatment of diseases resulting from nonsense mutations. They are investigating the use of engineered tRNAs for suppression of nonsense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) transcripts as therapeutic intervention for cystic fibrosis. Additionally, we am interested in the molecular genetics and experimental treatment of the trinucleotide repeat disorder myotonic dystrophy (DM1). Moving forward, we intend to study pre-mRNA splicing defects in DM1 to determine the causes of muscle weakness and wasting, and develop and test new therapeutic strategies to target the genetic misstep and reverse symptoms. More broadly, the lab is interested in applying membrane biophysics, molecular and cellular biology approaches to understand the molecular underpinning of genetic diseases and develop therapeutic interventions.

Attention Graduate Students, Undergraduate Students, Postdocs

We are looking for highly motivated individuals who are interested in conducting research in the area of RNA biology and their use as therapeutics and skeletal muscle ion channel biophysics. Please contact Professor Lueck and visit our working in the lab page for more details. 

John D. Lueck, Ph.D.

John D. Lueck, Ph.D.
Principal Investigator

Publications

widget-a11335b1-2b1

View All Publications

widget-161b2d69-39b

News

widget-74d6de09-a1c

Affiliations

April 27, 2023
Pulling the Plug on Viral Infections: CRISPR isn’t Just About Cutting

March 16, 2022
Congratulations to Lily Cisco and Chrissi Heil on their Myotonic Dystrophy Foundation Fellowships!

September 19, 2021
The Lueck Lab is quoted in Chemical & Engineering News!

April 29, 2021
Hocking and Lueck Receive EDI Medicines Discovery Awards

View All News

Contact Us

  Lueck Lab
601 Elmwood Ave
Rochester, NY 14642

 (585) 276-5489

  (585) 273-2652